ABCG2 and glioma: ABC transporters expressed in the blood–brain interfaces, the BBTB, and cancerous cells represent a selective barrier hindering the delivery of chemotherapeutics to gliomas and contribute importantly to their multidrug resistance, which is one of the causes of their high morbidity and mortality.